Cardinal Health extends CVS deal to 2032, trades 6.6% below target
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Cardinal Health has extended its pharmaceutical distribution agreement with CVS Health through June 30, 2032. This extension reaffirms Cardinal Health's fiscal year 2027 non-GAAP earnings-per-share growth guidance of 13-15% and long-term guidance of 12-14%. The company is set to release its first-quarter fiscal year 2027 results on November 5, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.